Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02564965
Other study ID # 14-001390
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date February 2019
Est. completion date December 2020

Study information

Verified date April 2019
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine optimal treatment strategies for symptomatic walled-off pancreatic necrosis( WON).


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2020
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Adult (> 18 yo) patients

- With symptomatic walled- off pancreatic necrosis in which an endoscopic approach is appropriate based on cross-sectional imaging

- Must have solid necrotic material present in their pancreatic fluid collection as determined by MRI, EUS, or direct transluminal endoscopic imaging of the collection

Exclusion Criteria:

- Previous intervention for pancreatic necrosis (surgical, percutaneous, or endoscopic)

- Indication for emergency laparotomy (compartment syndrome, bowel ischemia, bleeding, or perforation of a GI lumen)

- Uncorrectable coagulopathy.

Study Design


Intervention

Device:
Double Pigtail Plastic Stent
Patients will be stratified into two arms (Greater than 50% necrosis or less than 50% necrosis), then will be randomized to either the double pigtail plastic stent or AXIOS metal stent
AXIOS Metal Stent
Patients will be stratified into two arms (Greater than 50% necrosis or less than 50% necrosis), then will be randomized to either the double pigtail plastic stent or AXIOS metal stent

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Outcome

Type Measure Description Time frame Safety issue
Primary Complete resolution as defined by complete radiographic resolution of the walled-off necrosis (WON) Baseline to 4 months after initiation of endoscopic treatment
Secondary Clinical resolution of infection as defined by complete radiographic resolution and/or symptoms of pain and gastric outlet obstruction Baseline to 4 months after initiation of endoscopic treatment
Secondary Symptom resolution (Visual Analogue Scale for pain, gastric outlet obstruction, and weight gain) Baseline to 4 months after initiation of endoscopic treatment
Secondary Decrease in incidence of adverse events Baseline to 4 months after initiation of endoscopic treatment
Secondary Decrease in number of hospital days during treatment course Baseline to 4 months after initiation of endoscopic treatment
Secondary Decrease in total costs of pancreatitis-related health care during treatment course Baseline to 4 months after initiation of endoscopic treatment
See also
  Status Clinical Trial Phase
Completed NCT04986943 - ABTHERA ADVANCEā„¢ Use Without Wittman Patch
Completed NCT03694210 - EndoRotor DEN (Direct Endoscopic Necrosectomy)Trial N/A
Completed NCT01815489 - Molecular Analysis of Microbial DNA in Infected Necrotizing Pancreatitis
Not yet recruiting NCT04963868 - Timing of Transmural Stent Removal in Necrotizing Pancreatitis N/A
Completed NCT03115918 - Pancreatic Duct Stent for Acute Necrotizing Pancreatitis N/A
Not yet recruiting NCT06380842 - Organ Dysfunction Change in Acute Necrotizing Pancreatitis Patients With Sepsis After Open Necrosectomy

External Links